| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/29/2013 | WO2013124867A1 Polymer - polymer or polymer - protein core - shell nano medicine loaded with multiple drug molecules |
| 08/29/2013 | WO2013124865A1 Drug delivery system for finasteride to prostate |
| 08/29/2013 | WO2013124855A1 Hydrogel system comprising spatially separated bioactive polypeptides |
| 08/29/2013 | WO2013124820A1 Composition comprising a retinoid and benzoyl peroxide |
| 08/29/2013 | WO2013124818A1 Taste masked dispersible tablets |
| 08/29/2013 | WO2013124768A1 Bilayer tablet of dronedarone |
| 08/29/2013 | WO2013124463A1 Relaxin for treating patients afflicted of impaired glucose tolerance |
| 08/29/2013 | WO2013124444A1 Crosslinked polysaccharide beads comprising an imaging agent |
| 08/29/2013 | WO2013124415A1 Self-preserved oil dispersions comprising boric |
| 08/29/2013 | WO2013124340A1 Oral pharmaceutical compositions of dabigatran etexilate |
| 08/29/2013 | WO2013123965A1 A fixed dose pharmaceutical formulation |
| 08/29/2013 | WO2013123595A1 Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| 08/29/2013 | WO2013123569A1 Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| 08/29/2013 | WO2013079605A3 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| 08/29/2013 | WO2008004717A9 A stable liquid formulation of human growth hormone |
| 08/29/2013 | US20130226313 Bioactive Scaffold for Therapeutic and Adhesion Prevention Applications |
| 08/29/2013 | US20130226113 Uv stable transdermal therapeutic plaster with a uv absorbing adhesive layer separated from the drug matrix |
| 08/29/2013 | US20130226108 Self-destructing transdermal therapeutic system having improved functionality and efficacy |
| 08/29/2013 | US20130226061 Multi-layer bandages and methods for dressing a wound |
| 08/29/2013 | US20130225685 Combination composition |
| 08/29/2013 | US20130225643 Endogeneous repair factor production accelerators |
| 08/29/2013 | US20130225626 Sublingual films |
| 08/29/2013 | US20130225603 Mdm2 inhibitors for treatment of ocular conditions |
| 08/29/2013 | US20130225597 Use of phosphodiesterase inhibitor to enhance post-surgical erection in men undergoing radical prostatectomy |
| 08/29/2013 | US20130225492 Sustained-Release Pharmaceutical Composition |
| 08/29/2013 | US20130225489 Methods for administering hypoglycemic agents |
| 08/29/2013 | US20130225412 Silicon nanocarrier for delivery of drug, pesticides and herbicides , and for waste water treatment |
| 08/29/2013 | US20130224304 Effervescent nutritional and/or dietary supplement composition |
| 08/29/2013 | US20130224303 Process of producing shelf stable probiotic food |
| 08/29/2013 | US20130224302 Porous photonic crystals for drug delivery to the eye |
| 08/29/2013 | US20130224301 Solid pharmaceutical dispersions with enhanced bioavailability |
| 08/29/2013 | US20130224297 Pharmaceutical composition comprising krebs cycle precursor salt, in particular citrate salt, and use thereof as a medicament |
| 08/29/2013 | US20130224296 Drug Formulations Using Water Soluble Antioxidants |
| 08/29/2013 | US20130224295 Granule and orally-disintegrating tablet containing drug causing bitterness |
| 08/29/2013 | US20130224294 Dry processing of atazanavir |
| 08/29/2013 | US20130224290 Oral Pharmaceutical Composition of Duloxetine |
| 08/29/2013 | US20130224289 Gastric retained gabapentin dosage form |
| 08/29/2013 | US20130224287 Liposome-Based Construct Comprising a Peptide Modified Through Hydrophobic Moieties |
| 08/29/2013 | US20130224284 Geodate delivery vehicles |
| 08/29/2013 | US20130224283 Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery |
| 08/29/2013 | US20130224282 Multistage Nanoparticles |
| 08/29/2013 | US20130224281 Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress |
| 08/29/2013 | US20130224272 Compositions and methods for treating demodex infestations |
| 08/29/2013 | US20130224265 Dosage Forms for Tamper Prone Therapeutic Agents |
| 08/29/2013 | US20130224262 Transdermal preparation |
| 08/29/2013 | US20130224257 Method for preparing microspheres and microspheres produced thereby |
| 08/29/2013 | US20130224256 Hydrogel nanocomposite wound dressing and a method of synthesizing the same |
| 08/29/2013 | US20130224180 Injection paradigm for administration of botulinum toxins |
| 08/29/2013 | US20130224138 Lanolin substitute, production method thereof and applications of same |
| 08/29/2013 | US20130224133 Surfactant-free oil-in-water type emulsion, process for preparation thereof and its uses |
| 08/29/2013 | US20130224123 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 08/29/2013 | US20130224112 Compositions and methods for surface abrasion with frozen particles |
| 08/29/2013 | US20130220526 Films and Drug Delivery Systems Made Therefrom |
| 08/29/2013 | DE102012101680A1 Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat Pharmaceutical composition comprising an antivirally effective Dihydrochinazolinderivat |
| 08/29/2013 | DE102012003730A1 Producing comb polymers involves providing polyols as backbone, and reacting polyol with amino, ammonium, carboxyl, sulfonyl, sulfonic acid and/or phosphate group-containing compound to form negatively and/or positively charged side chains |
| 08/29/2013 | CA2848798A1 Formulation of doxylamine and pyridoxine and/or metabolites or salts thereof |
| 08/28/2013 | EP2630964A1 Method and medicament for treating patients in risk of prediabetes and type-2 diabetes |
| 08/28/2013 | EP2630960A1 Transdermal Delivery of Beneficial Substances Effected by a Hostile Biophysical Environment |
| 08/28/2013 | EP2630958A1 Solutions for bicarbonate hemodialysis |
| 08/28/2013 | EP2630956A2 Sustained-release pellets containing tacrolimus as an active ingredient |
| 08/28/2013 | EP2630955A1 Immediate release and sustained release ibuprofen dosing regimen |
| 08/28/2013 | EP2630954A1 Pulmonary delivery for levodopa |
| 08/28/2013 | EP2630953A1 Liposome composition and process for production thereof |
| 08/28/2013 | EP2630952A1 Self-preserved oil dispersions comprising boric acid |
| 08/28/2013 | EP2630951A1 Oral suspension of prednisolone acetate |
| 08/28/2013 | EP2629836A2 Silk fibroin-based microneedles and methods of making the same |
| 08/28/2013 | EP2629800A1 Composition for enteric hard capsules, and enteric hard capsule preparedusing the composition |
| 08/28/2013 | EP2629780A2 Implantable polymer for bone and vascular lesions |
| 08/28/2013 | EP2629779A2 Use of storage stable viscous phospholipid depot to treat wounds |
| 08/28/2013 | EP2629778A1 Use of mexiprostil in the treatment of inflammatory bowel disease and/or of irritable bowel syndrome |
| 08/28/2013 | EP2629775A1 Sustained-release formulation for injection |
| 08/28/2013 | EP2629763A1 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds |
| 08/28/2013 | EP2629762A1 Pendant hydrophile bearing biodegradable compositions and related devices |
| 08/28/2013 | EP2629761A1 Sustained-release tablet and process for preparing the same |
| 08/28/2013 | EP2629760A2 Therapeutic nanoparticles with high molecular weight copolymers |
| 08/28/2013 | EP2629759A2 Improved pharmaceutical starter pellets |
| 08/28/2013 | EP2629758A2 Metal ion nanoclusters |
| 08/28/2013 | EP2629757A2 Brimonidine gel compositions and methods of use |
| 08/28/2013 | EP2629756A1 Pharmaceutical topical composition of mupirocin |
| 08/28/2013 | EP2629755A1 Process for making multiparticulate gastroretentive dosage forms |
| 08/28/2013 | EP2629754A1 Liquid pharmaceutical composition for the delivery of active ingredients |
| 08/28/2013 | EP2331064B1 Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue |
| 08/28/2013 | CN203154350U Effect-persistent traditional Chinese medicine patch |
| 08/28/2013 | CN203154349U A hot compress medicated patch for treating dysmenorrhea |
| 08/28/2013 | CN203154348U Anti-dropping cow milk duct stype |
| 08/28/2013 | CN203154347U Hemorrhoids suppository |
| 08/28/2013 | CN1956724B Oral form of administration containing probiotic bacteria |
| 08/28/2013 | CN1955280B Potency regeneration cell and culturing method thereof |
| 08/28/2013 | CN1840051B Pain-stopping gel with musk and its preparation method |
| 08/28/2013 | CN103269716A Lyophilized viral formulations |
| 08/28/2013 | CN103269708A Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/28/2013 | CN103269698A Transdermal therapeutic system for administering an active substance |
| 08/28/2013 | CN103269696A Felbinac-containing external patch |
| 08/28/2013 | CN103269694A Pharmaceutical composition |
| 08/28/2013 | CN103269691A Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it |
| 08/28/2013 | CN103269690A Sustained-release polymeric microparticles containing poorly water-oluble drug and method for preparing the same |
| 08/28/2013 | CN103269689A Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same |
| 08/28/2013 | CN103269688A Tamper resistant dosage form comprising inorganic salt |
| 08/28/2013 | CN103269687A Bepotastine compositions |
| 08/28/2013 | CN103269686A Ophthalmic composition for contact lens |